(Q48318789)

10 February 2018

title

Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans. (English)

1 reference

10 February 2018

1 reference

2

1 reference

10 February 2018

author name string

Joshua A Lile

1

1 reference

10 February 2018

Paul E A Glaser

3

1 reference

10 February 2018

Lon R Hays

4

1 reference

10 February 2018

Craig R Rush

5

1 reference

10 February 2018

language of work or name

English

0 references

publication date

15 October 2010

1 reference

10 February 2018

Journal of Psychopharmacology

published in

1 reference

10 February 2018

volume

25

1 reference

10 February 2018

issue

11

1 reference

10 February 2018

page(s)

1469-1479

1 reference

10 February 2018

Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Pharmacokinetics and tolerability of intramuscular, oral and intravenous aripiprazole in healthy subjects and in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Modulation of the discriminative stimulus properties of cocaine: comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

The discriminative stimulus and subjective effects of d-amphetamine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Dopamine receptor partial agonists could address the duality of cocaine craving

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Pharmacokinetics of aripiprazole and concomitant lithium and valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Controversies in translational research: drug self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Electroencephalographic and psychomotor effects of chlorpromazine and risperidone relative to placebo in normal healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Varenicline: a novel pharmacotherapy for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Long-term haloperidol administration enhances and short-term administration attenuates the behavioral effects of cocaine in a place conditioning procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Interactions between chronic haloperidol treatment and cocaine in rats: an animal model of intermittent cocaine use in neuroleptic treated populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance II: increased aripipirazole dose and maintenance period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Subjective, cognitive/psychomotor, and physiological effects of aripiprazole in Chinese light and heavy smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Effects of hepatic or renal impairment on the pharmacokinetics of aripiprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Failure of ritanserin to block the discriminative or reinforcing stimulus effects of cocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Being partial to psychostimulant addiction therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Acute physiological and behavioral effects of oral cocaine in humans: a dose-response analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Serotonergic modulation of the discriminative-stimulus effects of cocaine in squirrel monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Dopamine D2/D3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Physiological, subjective and reinforcing effects of oral and intravenous cocaine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Development of an LC-MS/MS method for the simultaneous quantification of aripiprazole and dehydroaripiprazole in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Fluoxetine does not alter the ability of dopamine D(1)- and D(2)-like agonists to substitute for cocaine in squirrel monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Discriminative stimulus effects of cocaine in squirrel monkeys: lack of antagonism by the dopamine D2 partial agonists terguride, SDZ 208-911, and SDZ 208-912.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Oral Cocaine: Plasma Concentrations and Central Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

Intranasal and oral cocaine kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110385597

21 January 2018

Identifiers

DOI

10.1177/0269881110385597

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/b3laoa2gu5czdinw3hrrg44v5q

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_b3laoa2gu5czdinw3hrrg44v5q

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/b3laoa2gu5czdinw3hrrg44v5q

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/b3laoa2gu5czdinw3hrrg44v5q

1 reference